Chu CM - Search Results

1

Fumagillin treatment of hepatocellular carcinoma in rats: an in vivo study of antiangiogenesis.

Sheen IS, Jeng KS, Jeng WJ, Jeng CJ, Wang YC, Gu SL, Tseng SY, Chu CM, Lin CH, Chang KM. Sheen IS, et al. Among authors: chu cm. World J Gastroenterol. 2005 Feb 14;11(6):771-7. doi: 10.3748/wjg.v11.i6.771. World J Gastroenterol. 2005. PMID: 15682466 Free PMC article.

2

Prognostic significance of preoperative circulating vascular endothelial growth factor messenger RNA expression in resectable hepatocellular carcinoma: a prospective study.

Jeng KS, Sheen IS, Wang YC, Gu SL, Chu CM, Shih SC, Wang PC, Chang WH, Wang HY. Jeng KS, et al. Among authors: chu cm. World J Gastroenterol. 2004 Mar 1;10(5):643-8. doi: 10.3748/wjg.v10.i5.643. World J Gastroenterol. 2004. PMID: 14991930 Free PMC article.

3

Is the vascular endothelial growth factor messenger RNA expression in resectable hepatocellular carcinoma of prognostic value after resection?

Jeng KS, Sheen IS, Wang YC, Gu SL, Chu CM, Shih SC, Wang PC, Chang WH, Wang HY. Jeng KS, et al. Among authors: chu cm. World J Gastroenterol. 2004 Mar 1;10(5):676-81. doi: 10.3748/wjg.v10.i5.676. World J Gastroenterol. 2004. PMID: 14991937 Free PMC article.

4

Subcellular localization of hepatitis B core antigen in relation to hepatocyte regeneration in chronic hepatitis B.

Chu CM, Yeh CT, Sheen IS, Liaw YF. Chu CM, et al. Gastroenterology. 1995 Dec;109(6):1926-32. doi: 10.1016/0016-5085(95)90760-2. Gastroenterology. 1995. PMID: 7498658

5

The role of hepatitis C virus in fulminant viral hepatitis in an area with endemic hepatitis A and B.

Chu CM, Sheen IS, Liaw YF. Chu CM, et al. Gastroenterology. 1994 Jul;107(1):189-95. doi: 10.1016/0016-5085(94)90076-0. Gastroenterology. 1994. PMID: 8020661

6

Displacement of hepatitis B virus by hepatitis C virus as the cause of continuing chronic hepatitis.

Liaw YF, Tsai SL, Chang JJ, Sheen IS, Chien RN, Lin DY, Chu CM. Liaw YF, et al. Among authors: chu cm. Gastroenterology. 1994 Apr;106(4):1048-53. doi: 10.1016/0016-5085(94)90766-8. Gastroenterology. 1994. PMID: 8143971

7

Severe clinical rebound upon withdrawal of corticosteroid before interferon therapy: incidence and risk factors.

Sheen IS, Liaw YF, Lin SM, Chu CM. Sheen IS, et al. Among authors: chu cm. J Gastroenterol Hepatol. 1996 Feb;11(2):143-7. doi: 10.1111/j.1440-1746.1996.tb00051.x. J Gastroenterol Hepatol. 1996. PMID: 8672759

8

Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection.

Lin SM, Sheen IS, Chien RN, Chu CM, Liaw YF. Lin SM, et al. Among authors: chu cm. Hepatology. 1999 Mar;29(3):971-5. doi: 10.1002/hep.510290312. Hepatology. 1999. PMID: 10051505 Clinical Trial.

9

Low-level hepatitis C viremia and humoral immune response to NS4 in chronic hepatitis B virus-hepatitis C virus coinfection.

Chu CM, Sheen IS, Liaw YF. Chu CM, et al. Scand J Gastroenterol. 2004 Aug;39(8):778-82. doi: 10.1080/00365520410006332. Scand J Gastroenterol. 2004. PMID: 15513365

10

Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study.

Liaw YF, Tai DI, Chu CM, Lin DY, Sheen IS, Chen TJ, Pao CC. Liaw YF, et al. Among authors: chu cm. Gastroenterology. 1986 Feb;90(2):263-7. doi: 10.1016/0016-5085(86)90919-4. Gastroenterology. 1986. PMID: 2416625

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

683 results

Search Page

Filters